Hypercholesterolemia and Dyslipidemia: Issues for the Clinician. (Q51537186)

6 April 2018

title

Hypercholesterolemia and Dyslipidemia: Issues for the Clinician. (English)

1 reference

6 April 2018

0 references

1 reference

H. Robert Superko

1

1 reference

6 April 2018

Nicolas A. Chronos

series ordinal

2

1 reference

6 April 2018

publication date

1 February 2003

1 reference

6 April 2018

Current treatment options in cardiovascular medicine

published in

1 reference

6 April 2018

volume

5

1 reference

6 April 2018

issue

1

1 reference

6 April 2018

page(s)

35-50

1 reference

6 April 2018

Ischemic heart disease, atherosclerosis, and longevity.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0013-0

Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0013-0

Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0013-0

Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0013-0

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0013-0

High-density lipoprotein cholesterol and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0013-0

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0013-0

Plasma Protein Acute-Phase Response in Unstable Angina Is Not Induced by Ischemic Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0013-0

Mechanistic studies on metabolic interactions between gemfibrozil and statins

21 January 2018

1 reference

12 December 2020

The effect of apolipoprotein E isoform difference on postprandial lipoprotein in patients matched for triglycerides, LDL-cholesterol, and HDL-cholesterol

1 reference

12 December 2020

Did grandma give you heart disease? The new battle against coronary artery disease

1 reference

12 December 2020

Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)

1 reference

12 December 2020

Lipoprotein(a). A genetic risk factor for premature coronary heart disease

1 reference

12 December 2020

High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients

1 reference

12 December 2020

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

1 reference

12 December 2020

Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

12 December 2020

Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis

1 reference

12 December 2020

Hepatic lipase as a focal point for the development and treatment of coronary artery disease

1 reference

12 December 2020

Hyperlipoproteinemia: Metabolic basis and rationale for therapy

1 reference

12 December 2020

Apolipoprotein E polymorphism and atherosclerosis

1 reference

12 December 2020

The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia.

1 reference

12 December 2020

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

1 reference

12 December 2020

Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events

1 reference

12 December 2020

Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.

1 reference

12 December 2020

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

1 reference

12 December 2020

Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study.

1 reference

12 December 2020

High lipoprotein(a) in children from kindreds with parental premature myocardial infarction

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors

1 reference

12 December 2020

Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age

1 reference

12 December 2020

Abnormal in vivo metabolism of apolipoprotein E4 in humans

1 reference

12 December 2020

Effect of gemfibrozil in men with primary isolated low high-density lipoprotein cholesterol: a randomized, double-blind, placebo-controlled, crossover study.

1 reference

12 December 2020

Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women

1 reference

12 December 2020

What can we learn about dense low density lipoprotein and lipoprotein particles from clinical trials?

1 reference

12 December 2020

Elevated plasma concentrations of homocysteine in antiepileptic drug treatment

1 reference

12 December 2020

Familial hypoalphalipoproteinemia in premature coronary artery disease

1 reference

12 December 2020

Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

12 December 2020

High density lipoprotein cholesterol: prognosis after myocardial infarction. The Israeli Ischemic Heart Disease Study

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Familial hypo-alpha-lipoproteinemia

1 reference

12 December 2020

Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group

1 reference

12 December 2020

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

12 December 2020

Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy.

1 reference

12 December 2020

Atherogenic hyperlipoproteinemia. The cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol.

1 reference

12 December 2020

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

12 December 2020

Use of niacin, statins, and resins in patients with combined hyperlipidemia.

1 reference

12 December 2020

Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women

1 reference

12 December 2020

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

1 reference

12 December 2020

Beyond LDL cholesterol reduction

1 reference

12 December 2020

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

1 reference

12 December 2020

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

12 December 2020

Independent prognostic value of elevated C-reactive protein in unstable angina

1 reference

12 December 2020

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

12 December 2020

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

1 reference

12 December 2020

Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia.

1 reference

12 December 2020

Cerivastatin and reports of fatal rhabdomyolysis

1 reference

12 December 2020

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

1 reference

12 December 2020

Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a)

1 reference

12 December 2020

Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty

1 reference

12 December 2020

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

1 reference

12 December 2020

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment

1 reference

12 December 2020

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

1 reference

12 December 2020

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)

1 reference

12 December 2020

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

12 December 2020

Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention

1 reference

12 December 2020

Acute-phase proteins and other systemic responses to inflammation

1 reference

12 December 2020

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

1 reference

12 December 2020

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

1 reference

12 December 2020

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk

1 reference

12 December 2020

Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia

1 reference

12 December 2020

10.1007/S11936-003-0013-0

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018